These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31653644)

  • 1. Toward Combined Cell and Gene Therapy for Genodermatoses.
    De Rosa L; Latella MC; Secone Seconetti A; Cattelani C; Bauer JW; Bondanza S; De Luca M
    Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31653644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
    Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
    Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
    Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
    Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genodermatoses: candidate diseases for gene therapy.
    Uitto J; Pulkkinen L
    Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermolysis bullosa: where do we stand?
    Sarkar R; Bansal S; Garg VK
    Indian J Dermatol Venereol Leprol; 2011; 77(4):431-8. PubMed ID: 21727690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
    Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of congenital epidermolysis bullosa].
    de Raeve L; Ramet J; Danschutter D; Roseeuw D
    Ann Dermatol Venereol; 1998 Oct; 125(10):743-7. PubMed ID: 9835972
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural clues to genetic disorders of skin: the dermal-epidermal junction.
    Eady RA; McGrath JA; McMillan JR
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):13S-18S. PubMed ID: 7963675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for a lethal genetic blistering disease: a status report.
    Bauer EA; Herron GS; Marinkovich MP; Khavari PA; Lane AT
    Trans Am Clin Climatol Assoc; 1999; 110():86-92. PubMed ID: 10344009
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
    Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
    Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Epidermolysis Bullosa.
    Marinkovich MP; Tang JY
    J Invest Dermatol; 2019 Jun; 139(6):1221-1226. PubMed ID: 31068252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.
    De Rosa L; Carulli S; Cocchiarella F; Quaglino D; Enzo E; Franchini E; Giannetti A; De Santis G; Recchia A; Pellegrini G; De Luca M
    Stem Cell Reports; 2014 Jan; 2(1):1-8. PubMed ID: 24511464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.
    Bonafont J; Mencía A; Chacón-Solano E; Srifa W; Vaidyanathan S; Romano R; Garcia M; Hervás-Salcedo R; Ugalde L; Duarte B; Porteus MH; Del Rio M; Larcher F; Murillas R
    Mol Ther; 2021 Jun; 29(6):2008-2018. PubMed ID: 33609734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermolysis Bullosa: Pediatric Perspectives.
    Hon KL; Chu S; Leung AKC
    Curr Pediatr Rev; 2022; 18(3):182-190. PubMed ID: 34036913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
    Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
    N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK; Wang SP; Lee JY; McGrath JA
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
    Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
    J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.